XCancer

Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre, Prospective, Open-label, Single-arm Trial

Description:

To evaluate the efficacy and safety of yttrium-90 carbon microspheres in patients with unresectable hepatocellular carcinoma

Sponsor:

Zhongda Hospital

Phase:

Phase 1

Contacts:

Lei Zhang, MD

zhang_lei@seu.edu.cn

+862583262224

Hai-Dong Zhu, MD

zhuhaidong9509@163.com

+862583262224

Government Study Link:

NCT05957640 - Click here to see study on

ClinicalTrials.gov